Documents
ESG Charter Aescap January 14, 2022
Self-certification form individuals (FATCA)
Self-certification form entities (FATCA)
Aescap Life Sciences
Fact Sheet
Prospectus Aescap Life Sciences
Explanation amendments Prospectus Aescap Life Sciences
Supplement I to Prospectus Aescap Life Sciences
Explanation Supplement I to Prospectus Aescap Life Sciences
Subscription Form
Additional Subscription Form
Redemption form
Statement regarding Sustainable Finance Disclosure Regulation
Aescap Genetics
Prospectus Aescap Genetics
Subscription Form
Additional Subscription Form
Fund Manager
Semi-Annual Report 2021
Annual Report 2020
Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Semi-Annual Report 2018
Annual Report 2017
Semi-Annual Report 2017
Annual Report 2016
Semi-Annual Report 2016
Annual Report 2015
Semi-Annual Report 2015
Annual Report 2014
Annual Report 2013
Annual Report 2012
Aescap Life Sciences – Key Investor Document / Essentiële Beleggersinformatie
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors UK Unit Class
KID – Investors <500k Unit Class
KID – Investors Manager Unit Class
Key Information Investor Document Unit Class Aescap Life Sciences – Investors (NL)
Key Information Investor Document Unit Class Aescap Life Sciences – Investors < 500k (NL)
Aescap Genetics – Key Investor Document / Essentiële Beleggersinformatie
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors Manager Unit Class
EBI Aescap Genetics Investors (NL)
Financial Reports Aescap Life Sciences
